상세 보기
Phase Ib-II neoadjuvant chemotherapy with docetaxel plus atezolizumab plus herceptin SC and pertuzumab (TAHP) for patients with HER2-positive stage II/III breast cancer (NeoPATH) (KCSG BR 18-23, NCT03991878)
- Park, Y. H.;
- Im, S-A.;
- Sim, S. H.;
- Suh, K. J.;
- Kim, M. H.;
- ... Ahn, H. K.;
- 외 10명
Citations
WEB OF SCIENCE
2- 제목
- Phase Ib-II neoadjuvant chemotherapy with docetaxel plus atezolizumab plus herceptin SC and pertuzumab (TAHP) for patients with HER2-positive stage II/III breast cancer (NeoPATH) (KCSG BR 18-23, NCT03991878)
- 저자
- Park, Y. H.; Im, S-A.; Sim, S. H.; Suh, K. J.; Kim, M. H.; Ahn, H. K.; Jeong, J. H.; Kim, J-Y.; Lee, D-W.; Ahn, J-H.; Chae, H.; Lee, K-H.; Kim, J. H.; Lee, K. S.; Sohn, J. H.; Jung, K. H.
- 발행일
- 2021-09
- 유형
- Meeting Abstract
- 권
- 32
- 페이지
- S412 ~ S412